Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
NCT01066351Phase 3Unknown
- Sponsor
- Thammasat University
- Start
- Jan 2010
- Primary completion
- Mar 2011
- Modality
- Erythropoietins, Colony Stimulating Factors
- Countries
- 1
01
Overview
A Phase 3 trial of epoetin beta in acute kidney injury (AKI), sponsored by Thammasat University. Status: unknown.
02
Drugs
epoetin beta
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT01066351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01066351.